Cancer
Oncology·MeSH: Neoplasms
Prevalence
75.0 / 100K
Incidence
47.0 / 100K/yr
2439 drugs in development·407 companies·110 clinical trials
Drug Pipeline by Phase
Approved(124)
Phase 3(656)
Phase 2(552)
Phase 1(513)
Preclinical(168)
Unknown(48)
BLA Filed(1)
| Drug | Company |
|---|---|
| dcvax-l | NORTHWEST BIOTHERAPEUTICS INC (NWBO) |
Early Phase 1(17)
N/A(26)
Phase 1/Phase 2(169)
Phase 2/Phase 3(25)
Phase 4(140)
Compare drugs
Frequently asked questions
How many drugs are in development for Cancer?
BioSniper tracks 2439 drugs in development for Cancer across 407 companies.
How many clinical trials target Cancer?
There are 110 clinical trials targeting Cancer tracked by BioSniper.
What is the prevalence of Cancer?
The estimated prevalence of Cancer is approximately 75.0 per 100,000 population.
Deep-dive into Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis